BioXcel Therapeutics Inc.

NASDAQ: BTAI · Real-Time Price · USD
5.47
0.72 (15.16%)
At close: Aug 15, 2025, 3:59 PM
6.07
10.98%
After-hours: Aug 15, 2025, 07:58 PM EDT

BioXcel Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.25 -7.68 -58.09 -80.45
PEG Ratio
-0.00 -23.54 -1.12 -11.7
PS Ratio
6.69 996.30 25.68K n/a
PB Ratio
-0.16 -24.33 125.41 38.70
P/FCF Ratio
-0.21 -8.87 -71.07 -103.86
P/OCF Ratio
-0.21 -8.87 -71.14 -104.42
OCF/S Ratio
-31.79 -112.32 -360.91 n/a
Debt / Equity Ratio
-1.11 -1.79 1.23 0.01
Quick Ratio
1.65 2.57 6.11 14.21
Current Ratio
1.68 2.65 6.17 14.21
Asset Turnover
0.06 0.02 0.00 n/a
Interest Coverage
-4.44 -12.9 -19.44 -2.67K
Return on Equity
0.64 3.17 -2.16 -0.48
Return on Assets
-1.55 -2.43 -0.81 -0.45
Return on Invested Capital
-3.99 -3.65 -0.92 -0.47
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.05 0.09 0.95 n/a
Net Profit Margin
-26.3 -129.75 -442.02 n/a
Pretax Profit Margin
-26.3 -129.75 -442.02 n/a
Operating Profit Margin
-29.68 -124.48 -425.72 n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-19.49 -119.87 -419.69 n/a